The effects of nifedipine on platelet aggregation and plasma 6-keto-PGF1α, and its interaction with indomethacin

Summary Pre-incubation of human platelets with nifedipine in vitro or treatment of normal volunteers with nifedipine, 30 mg daily for one week, did not alter ADP induced aggregation measured by whole blood aggregometry. 6-oxo-Prostaglandin F₁ remained undetectable in plasma following oral administration of nifedipine to normal volunteers. The hypotensive response to intravenous nifedipine administration was similar in spontaneously hypertensive rats pretreated with indomethacin or placebo. These results conflict with previous reports that nifedipine alters platelet aggregation and prostaglandin metabolism.     

丹参和黄芪治疗气虚血瘀型心力衰竭的作用

本文报道91例气虚血瘀型心力衰竭(心衰)病人选用丹参和黄芪治疗作用。16例作气囊漂浮导管监测,发现黄芪明显增加心排出量、每搏量及心脏指数,而丹参无此作用,提示黄芪有正性肌力作用;30例给黄芪加党参,治疗后心功能分级及某些异常的血液流变学指标均有改善;44例先丹参,继之丹参加黄芪,治疗后心功能分级有明显改善,且能改善异常的血液流变学指标,明显抑制血小板聚集功能。提示丹参具有活血化瘀改善血液流变学及抑制血小板的聚集性,黄芪有补气强心改善心功能的作用。     

Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F_{1\alpha }

Summary Fenflumizole (2-(2,4-difluorophenyl)-4,5-bis(4-methoxyphenyl)imidazole), a new non-steroidal anti-inflammatory drug, was given to healthy subjects in single oral doses of 0.1, 1 and 2 mg/kg. The effect of the drug was followed for up to 8 h by repeated tests of arachidonic acid-induced platelet aggregation and was related to its concomitant plasma concentration. Fenflumizole reversibly inhibited platelet aggregation and the degree of inhibition was found to be linearly correlated with the log plasma concentration. There was depression of the formation of thromboxane B₂ and 6-keto-prostaglandin F₁ (the stable metabolites of thromboxane A₂ and prostacyclin) in clotted whole blood measured by radioimmunoassay after fenflumizole 1 mg/kg. This effect was directly related to the concentration of the drug in plasma, the maximum effect being reached at fenflumizole concentrations >200 ng/ml. EC₅₀-values for inhibition of the formation of thromboxane B₂ and 6-keto-prostaglandin were approximately 20 and 40 ng/ml, respectively. The results suggest that orally administered fenflumizole is a potent inhibitor of platelet aggregation and prostanoid formation.     

深圳市L区社区糖尿病患者自我管理模式探讨*

摘 要：目的：分析手足口病聚集性疫情在人群中的发生情况和分布特征。方法：收集2018年1月—2020年12月苏州 市各市 （区） 疾病预防控制中心每月上报的手足口病聚集性疫情信息,进行描述性统计分析。结果：2018—2020年苏州市共 报告手足口病聚集性疫情1 006起,报告病例3 129例,其中57.06%的疫情涉及2例病例。疫情发生的高峰期为每年的5—6月 和9月;报告疫情起数排在前三位的市 （区） 分别为张家港市、吴中区和太仓市;89.46%的疫情发生在幼托机构。采集342 起疫情的867例标本进行实验室检测,检出阳性病原的326起,占95.32%。阳性疫情以柯萨奇病毒A组6型 （CoxA6） 为主, 其次为柯萨奇病毒 A 组 16 型 （CoxA16）。结论：手足口病聚集性疫情呈现明显的双峰分布,幼托机构是疫情防控的重点场 所,病原存在单一感染和混合感染,不同年份病原构成存在差异。     

15种理气中药体外对人血小板聚集的影响

目的观察15种理气中药对体外肾上腺素诱导的人血小板聚集的影响.方法试管内人血小板加中药孵育前后,比浊法测定血小板聚集.结果11种理气药具有抗血小板聚集作用(P＜0.05～0.001),其中枳实的抑制作用较阳性对照阿司匹林明显(P＜0.01),青皮、陈皮与阿司匹林无差异(P＜0.05).柿蒂、甘松、檀香、沉香对血小板聚集无明显作用(P＞0.05).结论多数理气药(11/15)在体外具有抗人血小板聚集作用,枳实、青皮、陈皮3种作用强于或与阿司匹林相当.     

遗传因素在普通型偏头痛发生中的作用

目的探讨遗传因素在普通型偏头痛发生中的作用及该病的遗传方式.方法以27例普通型偏头痛患者为先证者,收集其一级和二级亲属的患病资料,采用零截尾泊松分布模型判断该病有无家庭聚集性,应用Penrose法和Li-Mantel-Gart法判断该病的遗传方式,应用PPAP软件估算该病的遗传度.结果先证者一级亲属该病的患病率＞二级亲属＞一般人群,符合多基因遗传病的特点;Penrose法的结果也显示该病为多基因遗传病,其一级亲属的遗传度为0.935±0.098,二级亲属的遗传度为0.439±0.284,遗传度的加权平均值为0824±0.093.结论普通型偏头痛是一种多基因遗传病.     

慢性肺源性心脏病人血液触变特性

本文用Low Shear 30流变测定仪,测定了55例肺心病患者全血触变特性的变化,分析了这些变化与肺心病发生和发展的关系。结果表明:肺心病患者血液的触变特性发生了异常改变。HCT、τ_o、η_s、μ、(η_s-μ)、A、ARC均升高,并随病情加重而逐渐明显。其原因主要在于肺心病缺氧所致的继发性红细胞增多及血液氧分压降低,和二氧化碳分压升高所致的红细胞变形性降低。血液触交特性的改变又使血液循环外周阻力增大,右心负荷增加,从而进一步加重了病情的发展。     

红细胞聚集与取向对其悬浮液电阻抗的影响——I.实验研究

本文通过测量具有不同流变特性的红细胞悬浮液电阻抗的动态与静态变化，研究了红细胞聚集与取向对其悬浮液电阻抗的影响。首次得出以下结论：１．红细胞聚集使其悬浮液电阻抗显著减小。２．由于低切变率下红细胞聚集与高切变率下红细胞取向的共同影响，使血液电阻抗随切变率的变化具有双相特性。这增加了对血液电特性的新认识，表明可利用电阻抗测定红细胞聚性。     

天麻提取物对血小板聚集的影响

目的观察天麻提取物对家兔体外、大鼠半离体和小鼠体内血小板聚集的影响.方法用比浊法测定血小板的聚集率.结果在体外、半离体和体内实验中,天麻提取物G2能抑制由二磷酸腺苷（ADP）诱导的血小板聚集;在体外实验中,天麻提取物G2还能抑制由血小板活化因子（PAF）诱导的血小板聚集.结论天麻提取物G2具有显著的抗血小板聚集作用.     

Islet-cell aggregates: Structure and insulin-producing activity during in vitro culture

Research Institute of Transplantology and Artificial Organs, Ministry of Health of the USSR, Moscow. (Presented by Academician of the Academy of Medical Sciences of the USSR A. P. Avtsyn.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 110, No. 12, pp. 650–653, December, 1990.